Authors observed neutrophils from T2D subjects with poor glycemic controls displayed downregulation of myeloperoxidase, S100A9, and azurocidin and upregulation of glycolytic enzymes such as alpha-enolase and transketolase (Soongsathitanon et al. 2019). The gene discussed is AZU1; the disease is type 2 diabetes mellitus.